Patents Assigned to Shionogi & Co.
  • Patent number: 8074427
    Abstract: A method and an apparatus for producing a container packing filler are provided, which ensure that a net can be correctly and speedily rolled up into a bulk or ball shape. A stretchable tubular net (N) is fitted around a columnar support member (6). Then, a distal portion of the net is forcibly folded radially outward or inward by a plurality of roller belts (30) disposed circumferentially of the net (N), while the roller belts (30) are moved toward a net proximal side axially of the net (N), whereby the net (N) is rolled up radially outward or inward with the distal portion thereof being forcibly folded by circular rotation and axial movement of the roller belts (30) to form an annular roll portion (C).
    Type: Grant
    Filed: March 29, 2007
    Date of Patent: December 13, 2011
    Assignees: Taisei Kako Co., Ltd., Shionogi & Co.
    Inventors: Yasuyuki Shiraishi, Kenji Ohnishi, Tomoyuki Fujita, Masato Tsuji, Shinji Hiramoto
  • Publication number: 20040180964
    Abstract: The present invention provides a pharmaceutical composition for use as an NPY Y5 receptor antagonist comprising a compound of the formula (I): 1
    Type: Application
    Filed: December 30, 2003
    Publication date: September 16, 2004
    Applicant: Shionogi & Co.
    Inventors: Yasuyuki Kawanishi, Hideyuki Takenaka, Kohji Hanasaki, Tetsuo Okada
  • Patent number: 5508276
    Abstract: A superior enteric formulation of the antidepressant drug, duloxetine, is in the form of enteric pellets of which the enteric layer comprises hydroxypropylmethylcellulose acetate succinate.
    Type: Grant
    Filed: July 18, 1994
    Date of Patent: April 16, 1996
    Assignees: Eli Lilly and Company, Shionogi & Co.
    Inventors: Neil R. Anderson, Peter L. Oren, Toshihiro Ogura, Toshiro Fujii
  • Patent number: 4659709
    Abstract: Highly effective diuretic antihypertensives, i.e., 2,3-dihydrobenzofuran-5-sulfonamide derivatives which is classified to loop diuretics with less adverse side-effects and can be administered orally at a daily dosage of 0.5-200 mg or parenterally of 0.01-50 mg.
    Type: Grant
    Filed: August 12, 1985
    Date of Patent: April 21, 1987
    Assignee: Shionogi & Co.
    Inventors: Hiroshi Harada, Yoshihiro Matsushita, Masuhisa Nakamura, Yukio Yonetani